The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStatPro Regulatory News (SOG)

  • There is currently no data for SOG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Statpro Group PLC

8 Oct 2019 15:16

RNS Number : 1754P
Tavira Securities Ltd
08 October 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Tavira Securities Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Funds for whom Tavira Securities Ltd is the investment manager

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Statpro Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 7th October 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORDINARY

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

 

2,169,811

3.29%

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

2,169,811

3.29%

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

ORD

CFD

 

Increasing a long position

142,729

228.5p

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 (c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

Not Applicable

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

Not Applicable

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

08/10/2019

Contact name:

Will Moody

Telephone number:

+44 203 192 1769

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETXVLFBKBFBFBL
Date   Source Headline
21st Feb 20087:00 amRNSAcquisition
18th Jan 20087:00 amRNSYear End Trading Update
21st Dec 200710:55 amRNSAdditional Listing
19th Dec 20077:01 amRNSDirector/PDMR Shareholding
14th Dec 20079:37 amRNSHolding(s) in Company
30th Nov 20079:48 amRNSAdditional Listing
22nd Nov 200710:12 amRNSDirector/PDMR Shareholding
8th Nov 20074:22 pmRNSDirector/PDMR Shareholding
19th Oct 20077:00 amRNSTrading Update
28th Sep 20073:49 pmRNSDirector/PDMR Shareholding
14th Sep 200710:40 amRNSAdditional Listing
21st Aug 200711:47 amRNSHolding(s) in Company
16th Aug 20073:57 pmRNSAIM Rule 26 Compliant Website
1st Aug 20079:00 amRNSDirector/PDMR Shareholding
30th Jul 20077:01 amRNSAcquisition
30th Jul 20077:01 amRNSInterim Results
12th Jul 20077:00 amRNSHalf Year Trading Update
5th Jun 20079:53 amRNSDirector/PDMR Shareholding
21st May 20079:13 amRNSDirector/PDMR Shareholding
16th May 20077:01 amRNSAGM Statement
10th May 20073:48 pmRNSHolding(s) in Company
10th May 20073:41 pmRNSHolding(s) in Company
30th Apr 200710:05 amRNSTotal Voting Rights
20th Apr 20072:53 pmRNSDirector/PDMR Shareholding
18th Apr 20074:03 pmRNSAnnual Report and Accounts
17th Apr 20072:47 pmRNSHolding(s) in Company
13th Apr 20079:00 amRNSAdditional Listing
12th Apr 20079:39 amRNSDirector/PDMR Shareholding
11th Apr 20075:37 pmRNSDirector/PDMR Shareholding
30th Mar 200712:00 pmRNSAdditional Listing
29th Mar 200710:03 amRNSTotal Voting Rights
22nd Mar 20079:44 amRNSHolding(s) in Company
19th Mar 20073:55 pmRNSAdditional Listing
16th Mar 200712:43 pmRNSHolding(s) in Company
12th Mar 20077:03 amRNSFinal Results
29th Jan 20072:18 pmRNSTotal Voting Rights
18th Jan 20072:33 pmRNSAdditional Listing
18th Jan 20077:01 amRNSTrading Statement
21st Dec 200611:53 amRNSTotal Voting Rights
21st Dec 200611:50 amRNSExercise of Option Agreement
19th Dec 20062:21 pmRNSAdditional Listing
4th Dec 20064:36 pmRNSAdditional Listing
30th Nov 20063:03 pmRNSDirector/PDMR Shareholding
7th Nov 200612:01 pmRNSAdditional Listing
27th Oct 20062:19 pmRNSHolding(s) in Company
25th Oct 20064:49 pmRNSDirector/PDMR Shareholding
17th Oct 200612:45 pmRNSHolding(s) in Company
2nd Oct 20063:41 pmRNSAdditional Listing
28th Sep 20062:45 pmRNSCircular Posted
27th Sep 20067:03 amRNSAcquisition & Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.